Ambler, PA, United States of America

Jeffrey W Schubert

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 12.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Ambler, PA (US) (2015 - 2016)
  • North Wales, PA (US) (2024)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Inventor Jeffrey W. Schubert: A Pioneer in Neurological Advancements

Introduction

Jeffrey W. Schubert, based in Ambler, Pennsylvania, is an innovative inventor with a remarkable contribution to the field of neuroscience. With three patents to his name, he has demonstrated a strong commitment to advancing therapies for neurological and psychiatric disorders. His extensive work has the potential to impact the lives of many individuals affected by these conditions.

Latest Patents

One of Schubert's latest patents, titled "3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor," focuses on the development of compounds that serve as allosteric modulators of the M4 receptor. These compounds hold promise for the treatment and prevention of various neurological and psychiatric disorders. Moreover, his patent also addresses compositions that encompass these compounds, expanding their potential therapeutic applications.

Another significant patent, "Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders," involves 4-pyridinone compounds designed to inhibit the catechol O-methyltransferase (COMT) enzyme. This innovation is aimed explicitly at treating and preventing conditions where COMT plays a critical role. The pharmaceutical compositions that incorporate these compounds offer additional avenues for tackling such complex disorders.

Career Highlights

Throughout his career, Jeffrey W. Schubert has been associated with reputable organizations such as Merck Sharp & Dohme Corporation and MSD R&D (China) Co., Ltd. His experiences in these companies have undoubtedly contributed to his robust understanding of pharmaceutical innovation and research.

Collaborations

Schubert has collaborated with noteworthy professionals in his field, including Scott T. Harrison and James J. Mulhearn. These partnerships have likely fostered a dynamic exchange of ideas and knowledge that enriches the research and development process.

Conclusion

In summary, Jeffrey W. Schubert stands out as a pivotal figure in the realm of neuroscience. With his inventive contributions and collaborations, he continues to pave the way for innovative solutions in the treatment of neurological and psychiatric disorders. His dedication and expertise hold significant promise for the future of medical advancements in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…